Selected research
Market Outlook & Growth Opportunities
Global Pet Blood Products Market Outlook and Growth Opportunities 2026
Market perspective
The global Pet Blood Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pet Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pet Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pet Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pet Blood Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pet Blood Products market include Lampire Biological Laboratories, IndyVet Blood Bank, Plasvacc USA, ABRI (Animal Blood Resources International) and APC (Agricultural Protein Company), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pet Blood Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pet Blood Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pet Blood Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Blood Products market size, projected growth trends, production technologies, key applications, and end-use industries.
Pet Blood Products Segment by Company
Lampire Biological Laboratories
IndyVet Blood Bank
Plasvacc USA
ABRI (Animal Blood Resources International)
APC (Agricultural Protein Company)
Pet Blood Products Segment by Type
Whole Blood
Blood Cells
Sheep Serum
Sheep Plasma
Others
Pet Blood Products Segment by Application
Veterinary & Food Safety
Immunology & Hematology
Pharmaceuticals & Diagnostics
Others
Pet Blood Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Pet Blood Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Pet Blood Products market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pet Blood Products significant trends, drivers, influence factors in global and regions.
6. To analyze Pet Blood Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pet Blood Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Blood Products industry.
Chapter 3: Detailed analysis of Pet Blood Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Pet Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Pet Blood Products in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Whole Blood
- Blood Cells
- Sheep Serum
- Sheep Plasma
- Others
Applications
- Veterinary & Food Safety
- Immunology & Hematology
- Pharmaceuticals & Diagnostics
- Others
Companies covered
- Lampire Biological Laboratories
- IndyVet Blood Bank
- Plasvacc USA
- ABRI (Animal Blood Resources International)
- APC (Agricultural Protein Company)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pet Blood Products Sales Value (2021-2032)
- 1.2.2 Global Pet Blood Products Sales Volume (2021-2032)
- 1.2.3 Global Pet Blood Products Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Pet Blood Products Market Dynamics
- 2.1 Pet Blood Products Industry Trends
- 2.2 Pet Blood Products Industry Drivers
- 2.3 Pet Blood Products Industry Opportunities and Challenges
- 2.4 Pet Blood Products Industry Restraints
3 Pet Blood Products Market by Company
- 3.1 Global Pet Blood Products Company Revenue Ranking in 2025
- 3.2 Global Pet Blood Products Revenue by Company (2021-2026)
- 3.3 Global Pet Blood Products Sales Volume by Company (2021-2026)
- 3.4 Global Pet Blood Products Average Price by Company (2021-2026)
- 3.5 Global Pet Blood Products Company Ranking (2024-2026)
- 3.6 Global Pet Blood Products Company Manufacturing Base and Headquarters
- 3.7 Global Pet Blood Products Company Product Type and Application
- 3.8 Global Pet Blood Products Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Pet Blood Products Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Pet Blood Products Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Pet Blood Products Market by Type
- 4.1 Pet Blood Products Type Introduction
- 4.1.1 Whole Blood
- 4.1.2 Blood Cells
- 4.1.3 Sheep Serum
- 4.1.4 Sheep Plasma
- 4.1.5 Others
- 4.2 Global Pet Blood Products Sales Volume by Type
- 4.2.1 Global Pet Blood Products Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pet Blood Products Sales Volume by Type (2021-2032)
- 4.2.3 Global Pet Blood Products Sales Volume Share by Type (2021-2032)
- 4.3 Global Pet Blood Products Sales Value by Type
- 4.3.1 Global Pet Blood Products Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pet Blood Products Sales Value by Type (2021-2032)
- 4.3.3 Global Pet Blood Products Sales Value Share by Type (2021-2032)
5 Pet Blood Products Market by Application
- 5.1 Pet Blood Products Application Introduction
- 5.1.1 Veterinary & Food Safety
- 5.1.2 Immunology & Hematology
- 5.1.3 Pharmaceuticals & Diagnostics
- 5.1.4 Others
- 5.2 Global Pet Blood Products Sales Volume by Application
- 5.2.1 Global Pet Blood Products Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pet Blood Products Sales Volume by Application (2021-2032)
- 5.2.3 Global Pet Blood Products Sales Volume Share by Application (2021-2032)
- 5.3 Global Pet Blood Products Sales Value by Application
- 5.3.1 Global Pet Blood Products Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pet Blood Products Sales Value by Application (2021-2032)
- 5.3.3 Global Pet Blood Products Sales Value Share by Application (2021-2032)
6 Pet Blood Products Regional Sales and Value Analysis
- 6.1 Global Pet Blood Products Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pet Blood Products Sales by Region (2021-2032)
- 6.2.1 Global Pet Blood Products Sales by Region: 2021-2026
- 6.2.2 Global Pet Blood Products Sales by Region (2027-2032)
- 6.3 Global Pet Blood Products Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Pet Blood Products Sales Value by Region (2021-2032)
- 6.4.1 Global Pet Blood Products Sales Value by Region: 2021-2026
- 6.4.2 Global Pet Blood Products Sales Value by Region (2027-2032)
- 6.5 Global Pet Blood Products Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Pet Blood Products Sales Value (2021-2032)
- 6.6.2 North America Pet Blood Products Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Pet Blood Products Sales Value (2021-2032)
- 6.7.2 Europe Pet Blood Products Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Pet Blood Products Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Pet Blood Products Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Pet Blood Products Sales Value (2021-2032)
- 6.9.2 South America Pet Blood Products Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Pet Blood Products Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Pet Blood Products Sales Value Share by Country, 2025 VS 2032
7 Pet Blood Products Country-level Sales and Value Analysis
- 7.1 Global Pet Blood Products Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pet Blood Products Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Pet Blood Products Sales by Country (2021-2032)
- 7.3.1 Global Pet Blood Products Sales by Country (2021-2026)
- 7.3.2 Global Pet Blood Products Sales by Country (2027-2032)
- 7.4 Global Pet Blood Products Sales Value by Country (2021-2032)
- 7.4.1 Global Pet Blood Products Sales Value by Country (2021-2026)
- 7.4.2 Global Pet Blood Products Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.9.2 France Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.16.2 China Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.19.2 India Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Pet Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Pet Blood Products Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Pet Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Pet Blood Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Lampire Biological Laboratories
- 8.1.1 Lampire Biological Laboratories Company Information
- 8.1.2 Lampire Biological Laboratories Business Overview
- 8.1.3 Lampire Biological Laboratories Pet Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Lampire Biological Laboratories Pet Blood Products Product Portfolio
- 8.1.5 Lampire Biological Laboratories Recent Developments
- 8.2 IndyVet Blood Bank
- 8.2.1 IndyVet Blood Bank Company Information
- 8.2.2 IndyVet Blood Bank Business Overview
- 8.2.3 IndyVet Blood Bank Pet Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.2.4 IndyVet Blood Bank Pet Blood Products Product Portfolio
- 8.2.5 IndyVet Blood Bank Recent Developments
- 8.3 Plasvacc USA
- 8.3.1 Plasvacc USA Company Information
- 8.3.2 Plasvacc USA Business Overview
- 8.3.3 Plasvacc USA Pet Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Plasvacc USA Pet Blood Products Product Portfolio
- 8.3.5 Plasvacc USA Recent Developments
- 8.4 ABRI (Animal Blood Resources International)
- 8.4.1 ABRI (Animal Blood Resources International) Company Information
- 8.4.2 ABRI (Animal Blood Resources International) Business Overview
- 8.4.3 ABRI (Animal Blood Resources International) Pet Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.4.4 ABRI (Animal Blood Resources International) Pet Blood Products Product Portfolio
- 8.4.5 ABRI (Animal Blood Resources International) Recent Developments
- 8.5 APC (Agricultural Protein Company)
- 8.5.1 APC (Agricultural Protein Company) Company Information
- 8.5.2 APC (Agricultural Protein Company) Business Overview
- 8.5.3 APC (Agricultural Protein Company) Pet Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.5.4 APC (Agricultural Protein Company) Pet Blood Products Product Portfolio
- 8.5.5 APC (Agricultural Protein Company) Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pet Blood Products Value Chain Analysis
- 9.1.1 Pet Blood Products Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pet Blood Products Sales Mode & Process
- 9.2 Pet Blood Products Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pet Blood Products Distributors
- 9.2.3 Pet Blood Products Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst